Terms: = Gastric cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
8423 results:
1. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
2. Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced gastric cancer: treatment Pattern and Survival Analysis of a 20-Year Real-World Study.
Cao ND; Zhu XH; Ma FQ; Xu Y; Dong JH; Qin MM; Liu TS; Zhu CC; Guo WJ; Ding HH; Guo YB; Liu LK; Song JJ; Wu JP; Cheng YL; Zeng L; Zhao AG
Chin J Integr Med; 2024 Jun; 30(6):489-498. PubMed ID: 38801641
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract] [Full Text] [Related]
4. An On-treatment Decreased Trend of Serum IL-6 and IL-8 as Predictive Markers Quickly Reflects Short-Term Efficacy of PD-1 Blockade Immunochemotherapy in Patients with Advanced gastric cancer.
Liu J; Mao Y; Mao C; Wang D; Dong L; Zhu W
J Immunol Res; 2024; 2024():3604935. PubMed ID: 38774604
[TBL] [Abstract] [Full Text] [Related]
5. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.
Bišof V; Katić A; Soče M; Vidović M; Viculin J; Pleština S; Vrdoljak E
Neoplasma; 2024 Apr; 71(2):201-208. PubMed ID: 38766850
[TBL] [Abstract] [Full Text] [Related]
6. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
8. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
9. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
[TBL] [Abstract] [Full Text] [Related]
10. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
11. Effects of perioperative low-dose naloxone on the immune system in patients undergoing laparoscopic-assisted total gastrectomy: a randomized controlled trial.
Min X; Ma Y; Leng Y; Li X; Zhang J; Xu S; Wang X; Lv R; Guo J; Xing H
BMC Anesthesiol; 2024 May; 24(1):172. PubMed ID: 38720250
[TBL] [Abstract] [Full Text] [Related]
12. Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells.
Zhang B; Tang Q; Shi W; Bao Z; Gao S; Pan C
Cell Cycle; 2024 Mar; 23(5):602-612. PubMed ID: 38717991
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
14. Is there any difference between Eastern and Western clinical practice guidelines in management of gastric cancer?
Jalaeefar A; Mousavi SZ; Shirkhoda M; Mahmoodzadeh H; Mohammadzadeh N; Sharifi A
Cancer Rep (Hoboken); 2024 May; 7(5):e2076. PubMed ID: 38711281
[TBL] [Abstract] [Full Text] [Related]
15. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
[TBL] [Abstract] [Full Text] [Related]
16. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
17. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract] [Full Text] [Related]
18. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
[TBL] [Abstract] [Full Text] [Related]
19. EBV-Associated gastric cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.
Abolhasani M; Mohseni AO; Shakeri R; Khavanin A; Khajehei M; Omidi A; Geramizadeh B; Shafigh E; Naghshvar F; Fathizadeh P; Taghizadehgan L; Gharib A; Gulley ML; Dawsey SM; Malekzadeh R; Rabkin CS; Vasei M
Arch Iran Med; 2024 Apr; 27(4):191-199. PubMed ID: 38685845
[TBL] [Abstract] [Full Text] [Related]
20. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
[Next]
